Synergistic anti-ageing through senescent cells specific reprogramming

• Verfasst von: Chen, Rui [VerfasserIn]
• Verfasst von: Skutella, Thomas [VerfasserIn]
• Titel: Synergistic anti-ageing through senescent cells specific reprogramming
• Verf.angabe: Rui Chen and Thomas Skutella
• E-Jahr: 2022
• Jahr: 28 February 2022
• Umfang: 20 S.
• Fussnoten: Gesehen am 07.04.2022
• Titel Quelle: Enthalten in: Cells
• Ort Quelle: Basel : MDPI, 2012
• Jahr Quelle: 2022
• Band/Heft Quelle: 11(2022), 5, Artikel-ID 830, Seite 1-20
• ISSN Quelle: 2073-4409
• DOI: doi:10.3390/cells11050830
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: ageing
• Sach-SW: p16^Ink4a
• Sach-SW: p19^Arf
• Sach-SW: p21^Waf1/Cip1
• Sach-SW: SASP
• Sach-SW: senescence
• Sach-SW: senolytics/senostatics
• K10plus-PPN: 1798137224

Abstract

In this review, we seek a novel strategy for establishing a rejuvenating microenvironment through senescent cells specific reprogramming. We suggest that partial reprogramming can produce a secretory phenotype that facilitates cellular rejuvenation. This strategy is desired for specific partial reprogramming under control to avoid tumour risk and organ failure due to loss of cellular identity. It also alleviates the chronic inflammatory state associated with ageing and secondary senescence in adjacent cells by improving the senescence-associated secretory phenotype. This manuscript also hopes to explore whether intervening in cellular senescence can improve ageing and promote damage repair, in general, to increase people’s healthy lifespan and reduce frailty. Feasible and safe clinical translational protocols are critical in rejuvenation by controlled reprogramming advances. This review discusses the limitations and controversies of these advances’ application (while organizing the manuscript according to potential clinical translation schemes) to explore directions and hypotheses that have translational value for subsequent research.